Sign in

You're signed outSign in or to get full access.

Victoria J. Reich

Director at IngredionIngredion
Board

About Victoria J. Reich

Independent director of Ingredion since November 2013; age 67. She is Chair of the Audit Committee and has been designated an “audit committee financial expert” under SEC rules. Former Senior Vice President and Chief Financial Officer of Essendant Inc. (formerly United Stationers Inc.). Current outside public company directorships include H&R Block, Inc. (Audit Committee Chair; Finance Committee member) and Ecolab Inc. (director; currently on Audit and Governance Committees; former Audit Chair). Also serves as a director of Logan Health Whitefish Hospital (non‑profit). The Board has determined she is independent under NYSE standards.

Past Roles

OrganizationRoleTenureCommittees/Impact
Essendant Inc. (f/k/a United Stationers Inc.)Senior Vice President & Chief Financial OfficerJun 2007 – Jul 2011Corporate finance leadership; CFO of a public company
Various (career overview)Corporate financial and accounting roles; controller; operating/general management incl. international30+ yearsExperience cited by INGR Board as basis for service; qualifies as audit committee financial expert

External Roles

OrganizationRoleCommittee AssignmentsNotes / Interlocks
H&R Block, Inc. (NYSE: HRB)DirectorAudit Committee Chair; Finance Committee memberCurrent public directorship
Ecolab Inc. (NYSE: ECL)DirectorAudit and Governance Committees (former Audit Chair)Ecolab is also in INGR’s Performance Peer Group for PSU rTSR benchmarking (potential interlock consideration)
Logan Health Whitefish HospitalDirectorNon‑profit board service

Board Governance

  • Independence and attendance
    • Determined independent under NYSE rules; serves as an Audit Committee member and Chair meeting heightened independence requirements. The Board held 6 meetings in 2024, and each director attended at least 75% of Board and relevant committee meetings; all 11 directors attended the 2024 annual meeting.
  • Committee assignments and activity levels
    • Audit Committee: Chair (members: Reich (Chair), Suever, Wilson). The committee met 10 times in 2024. Responsibilities include oversight of financial reporting, internal controls, enterprise risk management (including cybersecurity), capital structure/liquidity, and related‑party transaction review/approval. Reich is designated an audit committee financial expert.
  • Related‑party transactions oversight
    • Policy requires Audit Committee or independent directors to approve/ratify related‑person transactions >$120,000; since Jan 1, 2024, none required approval (no related‑person transactions disclosed).
  • Executive sessions and leadership
    • Non‑employee directors hold executive sessions at each regular Board meeting; the independent Chairman presides.

Fixed Compensation (Non‑Employee Director)

ElementAmount/TermNotes
Annual Cash Retainer$105,000 (paid quarterly)Standard director cash retainer
Audit Committee Chair Retainer$25,000 (cash)Additional for Audit Chair responsibilities
Annual Equity Retainer$160,000 (paid quarterly in stock; immediately vested; RSU deferral available)Shares calculated using trailing 20‑day average price; RSUs if deferred until ≥6 months post‑service
Meeting FeesNoneExpenses reimbursed; no per‑meeting fees

2024 actual compensation for Ms. Reich:

NameFees Earned (Cash)Stock Awards (Grant‑date FV)All Other CompensationTotal
Victoria J. Reich$130,000$159,863$7,000$296,863
Notes: “All Other Compensation” reflects charitable match under company program.

Performance Compensation

  • Non‑employee directors do not receive performance‑based incentives; equity retainers are time‑based and immediately vested (or deferred).
  • As part of board oversight of pay‑for‑performance for executives, the company’s active incentive metrics in 2024 were:

Annual Incentive Plan (AIP) – 2024 metrics and results

Metric (Weight)ThresholdTargetMaximum2024 AchievementPayout (component)
Adjusted EBITDA (70% of plan)$1,014.9m$1,194.0m$1,313.4m$1,228.3m128.7%
Working Capital % Net Sales (15%)26.2%22.8%19.4%20.1%180.5%
Cost/Productivity (15%)$15.3m$18.0m$24.0m$23.5m191.7%

Long‑Term Incentive (PSUs) – 2024–2026 plan design and 2022–2024 results

CycleMetric (50%/50%)ThresholdTargetMaximumActual/StatusPayout
2024–2026 (in flight)Adjusted ROIC; rTSR vs 20‑company peer group<8% / <25th pct10% / 50th pct≥12% / ≥75th pctOngoing
2022–2024 (completed)Adjusted ROIC; rTSR vs 19‑company peer group<8% / <25th pct10% / Median≥11.5% / ≥75th pct13.0% ROIC; 95th pct rTSR200%

Say‑on‑Pay result: 93% approval at 2024 annual meeting (indicator of shareholder alignment on pay program).

Other Directorships & Interlocks

CompanySector Link to INGRInterlock/Conflict Consideration
Ecolab Inc. (ECL)Included in INGR’s 2024 Performance Peer Group used for PSU rTSR benchmarkingAppearance of interlock to monitor; not a related‑party transaction and not inherently conflicted. Board retains independent consultant and policies mitigate conflicts.
H&R Block, Inc. (HRB)Not in INGR peer setsNo competitive or supplier/customer linkage disclosed.

Expertise & Qualifications

  • Audit committee financial expert; former public company CFO; deep corporate finance and accounting experience; operating/general management with international responsibility.
  • Board governance experience across multiple public companies (audit, finance, governance committees).

Equity Ownership

ItemValue
Common stock owned outright (as of Mar 24, 2025)0 shares (beneficial ownership)
Shares underlying phantom stock units and RSUs (as of Mar 24, 2025)17,830 units (no voting/investment power)
RSUs accumulated via director deferral account (as of Dec 31, 2024)17,726 units (includes dividend equivalents)
Director stock ownership guideline5× annual cash retainer (currently $525,000); 5‑year window; counts common, vested/unvested restricted stock/RSUs/phantom
Compliance status (board‑wide)All non‑employee directors either exceed guidelines or are within the 5‑year window
Hedging/pledging policyDirectors and executive officers prohibited from hedging; pledging generally prohibited with narrow exception requiring capacity to repay loan without the pledged securities; no exceptions disclosed for Ms. Reich
Section 16 complianceNo delinquencies disclosed for Ms. Reich in 2024; one director (Uribe) noted with late Forms 4 for trust transfers (unrelated to Reich)

Governance Assessment

  • Strengths

    • Deep financial expertise and public‑company CFO background; Audit Committee Chair and SEC‑designated financial expert status strengthen oversight of reporting, controls, ERM, and cybersecurity.
    • Independent status; robust committee independence standards met; active committee cadence (Audit met 10x in 2024).
    • No related‑party transactions disclosed since Jan 1, 2024; strong related‑person transaction approval policy.
    • Director ownership policy promotes alignment; equity retainer paid in stock with deferral option; board‑wide compliance with ownership guidelines.
    • Shareholder support for pay program (93% Say‑on‑Pay) signals broad investor confidence in compensation governance.
  • Watch items

    • Multiple audit leadership roles (Audit Chair at H&R Block; former Audit Chair and current committee member at Ecolab) plus Audit Chair at INGR elevate time/complexity demands; monitor for workload/overboarding risk as responsibilities evolve.
    • Outright common stock ownership is 0 as of record date, though substantial deferred RSU/phantom holdings are counted toward ownership guidelines; some investors prefer larger outright share holdings for optics.
  • Red flags

    • None disclosed: no related‑party transactions, no Section 16 issues for Reich, and company prohibits hedging/pledging (with narrow pledging exception requiring safeguards).